Logo image of EGBN

EAGLE BANCORP INC (EGBN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EGBN - US2689481065 - Common Stock

22.15 USD
+0.2 (+0.91%)
Last: 1/9/2026, 1:19:31 PM
Fundamental Rating

2

EGBN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 387 industry peers in the Banks industry. EGBN may be in some trouble as it scores bad on both profitability and health. EGBN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EGBN has reported negative net income.
In the past year EGBN had a positive cash flow from operations.
EGBN had positive earnings in 4 of the past 5 years.
EGBN had a positive operating cash flow in each of the past 5 years.
EGBN Yearly Net Income VS EBIT VS OCF VS FCFEGBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

EGBN has a Return On Assets of -1.12%. This is amonst the worse of the industry: EGBN underperforms 94.57% of its industry peers.
EGBN has a worse Return On Equity (-10.74%) than 94.32% of its industry peers.
Industry RankSector Rank
ROA -1.12%
ROE -10.74%
ROIC N/A
ROA(3y)0.57%
ROA(5y)0.88%
ROE(3y)5.18%
ROE(5y)7.85%
ROIC(3y)N/A
ROIC(5y)N/A
EGBN Yearly ROA, ROE, ROICEGBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

EGBN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EGBN Yearly Profit, Operating, Gross MarginsEGBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

EGBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EGBN has more shares outstanding
EGBN has less shares outstanding than it did 5 years ago.
EGBN has a better debt/assets ratio than last year.
EGBN Yearly Shares OutstandingEGBN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EGBN Yearly Total Debt VS Total AssetsEGBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

The Debt to FCF ratio of EGBN is 2.29, which is a good value as it means it would take EGBN, 2.29 years of fcf income to pay off all of its debts.
EGBN's Debt to FCF ratio of 2.29 is in line compared to the rest of the industry. EGBN outperforms 43.67% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that EGBN is not too dependend on debt financing.
The Debt to Equity ratio of EGBN (0.08) is better than 72.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.29
Altman-Z N/A
ROIC/WACCN/A
WACC18.72%
EGBN Yearly LT Debt VS Equity VS FCFEGBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
EGBN Yearly Current Assets VS Current LiabilitesEGBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for EGBN have decreased strongly by -293.17% in the last year.
Measured over the past years, EGBN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.37% on average per year.
The Revenue has decreased by -5.20% in the past year.
EGBN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.47% yearly.
EPS 1Y (TTM)-293.17%
EPS 3Y-30.16%
EPS 5Y-15.37%
EPS Q2Q%-408.33%
Revenue 1Y (TTM)-5.2%
Revenue growth 3Y-5.43%
Revenue growth 5Y-2.47%
Sales Q2Q%-3.04%

3.2 Future

Based on estimates for the next years, EGBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.04% on average per year.
The Revenue is expected to decrease by -0.44% on average over the next years.
EPS Next Y-296.44%
EPS Next 2Y-7.85%
EPS Next 3Y12.04%
EPS Next 5YN/A
Revenue Next Year-7.01%
Revenue Next 2Y-2.7%
Revenue Next 3Y-0.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EGBN Yearly Revenue VS EstimatesEGBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
EGBN Yearly EPS VS EstimatesEGBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

1

4. Valuation

4.1 Price/Earnings Ratio

EGBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 13.87, EGBN is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EGBN indicates a slightly more expensive valuation: EGBN is more expensive than 70.80% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.70. EGBN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 13.87
EGBN Price Earnings VS Forward Price EarningsEGBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EGBN is valued a bit more expensive than 68.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.08
EV/EBITDA N/A
EGBN Per share dataEGBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

EGBN's earnings are expected to grow with 12.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.85%
EPS Next 3Y12.04%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.19%, EGBN is not a good candidate for dividend investing.
With a Dividend Yield of 0.19, EGBN pays less dividend than the industry average, which is at 2.78. 87.08% of the companies listed in the same industry pay a better dividend than EGBN!
With a Dividend Yield of 0.19, EGBN pays less dividend than the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

On average, the dividend of EGBN grows each year by 17.91%, which is quite nice.
EGBN has been paying a dividend for at least 10 years, so it has a reliable track record.
EGBN has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)17.91%
Div Incr Years5
Div Non Decr Years5
EGBN Yearly Dividends per shareEGBN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

EGBN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of EGBN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-16.59%
EPS Next 2Y-7.85%
EPS Next 3Y12.04%
EGBN Yearly Income VS Free CF VS DividendEGBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

EAGLE BANCORP INC

NASDAQ:EGBN (1/9/2026, 1:19:31 PM)

22.15

+0.2 (+0.91%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)01-21 2026-01-21/amc
Inst Owners82.91%
Inst Owner Change0%
Ins Owners7.57%
Ins Owner Change-0.35%
Market Cap672.70M
Revenue(TTM)293.56M
Net Income(TTM)-120.61M
Analysts78
Price Target21.29 (-3.88%)
Short Float %11.88%
Short Ratio6.65
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend1.52
Dividend Growth(5Y)17.91%
DP-16.59%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1039.2%
Min EPS beat(2)-1462.99%
Max EPS beat(2)-615.41%
EPS beat(4)1
Avg EPS beat(4)-541.55%
Min EPS beat(4)-1462.99%
Max EPS beat(4)0.04%
EPS beat(8)3
Avg EPS beat(8)-269.53%
EPS beat(12)6
Avg EPS beat(12)-176.42%
EPS beat(16)8
Avg EPS beat(16)-132.24%
Revenue beat(2)0
Avg Revenue beat(2)-6.21%
Min Revenue beat(2)-7.31%
Max Revenue beat(2)-5.1%
Revenue beat(4)0
Avg Revenue beat(4)-9.16%
Min Revenue beat(4)-13.86%
Max Revenue beat(4)-5.1%
Revenue beat(8)1
Avg Revenue beat(8)-6.08%
Revenue beat(12)3
Avg Revenue beat(12)-4.47%
Revenue beat(16)7
Avg Revenue beat(16)-2.17%
PT rev (1m)5.03%
PT rev (3m)4.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1447.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.9%
Revenue NQ rev (1m)-1.49%
Revenue NQ rev (3m)-12.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.87
P/S 2.29
P/FCF 17.08
P/OCF 15.15
P/B 0.6
P/tB 0.6
EV/EBITDA N/A
EPS(TTM)-3.96
EYN/A
EPS(NY)1.6
Fwd EY7.21%
FCF(TTM)1.3
FCFY5.85%
OCF(TTM)1.46
OCFY6.6%
SpS9.67
BVpS36.99
TBVpS36.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.12%
ROE -10.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 13.41%
ROA(3y)0.57%
ROA(5y)0.88%
ROE(3y)5.18%
ROE(5y)7.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.29
Debt/EBITDA N/A
Cap/Depr 150.16%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC18.72%
ROIC/WACCN/A
Cap/Depr(3y)25.28%
Cap/Depr(5y)45.47%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-293.17%
EPS 3Y-30.16%
EPS 5Y-15.37%
EPS Q2Q%-408.33%
EPS Next Y-296.44%
EPS Next 2Y-7.85%
EPS Next 3Y12.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.2%
Revenue growth 3Y-5.43%
Revenue growth 5Y-2.47%
Sales Q2Q%-3.04%
Revenue Next Year-7.01%
Revenue Next 2Y-2.7%
Revenue Next 3Y-0.44%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-79.64%
FCF growth 3Y-19.09%
FCF growth 5Y-1.01%
OCF growth 1Y-77.14%
OCF growth 3Y-19.63%
OCF growth 5Y-1.38%

EAGLE BANCORP INC / EGBN FAQ

What is the fundamental rating for EGBN stock?

ChartMill assigns a fundamental rating of 2 / 10 to EGBN.


Can you provide the valuation status for EAGLE BANCORP INC?

ChartMill assigns a valuation rating of 1 / 10 to EAGLE BANCORP INC (EGBN). This can be considered as Overvalued.


Can you provide the profitability details for EAGLE BANCORP INC?

EAGLE BANCORP INC (EGBN) has a profitability rating of 2 / 10.


Can you provide the financial health for EGBN stock?

The financial health rating of EAGLE BANCORP INC (EGBN) is 3 / 10.


What is the earnings growth outlook for EAGLE BANCORP INC?

The Earnings per Share (EPS) of EAGLE BANCORP INC (EGBN) is expected to decline by -296.44% in the next year.